LBD
WST icon

Landsberg Bennett & Dubbaneh’s West Pharmaceutical WST Stock Holding History

Landsberg Bennett & Dubbaneh’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$405K Buy
965
+221
+30% +$93.2K 0.05% 188
2021
Q2 		$268K Buy
+744
New +$246K 0.03% 242

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Landsberg Bennett & Dubbaneh's WST Position: Q3 2021 in Review

Landsberg Bennett & Dubbaneh increased its West Pharmaceutical (WST) stake by 30% in Q3 2021, buying an estimated $93.2K and bringing the position to 965 shares worth $405K. The position accounts for 0.05% of the portfolio, ranked #188.

Landsberg Bennett & Dubbaneh first reported a position in WST in Q2 2021 and has held it in 2 quarters since. 670 funds tracked by Wall St. Rank hold WST as of Q3 2021.

  • Landsberg Bennett & Dubbaneh held 965 shares of West Pharmaceutical worth $405K as of Q3 2021.
  • Landsberg Bennett & Dubbaneh bought 221 West Pharmaceutical shares in Q3 2021, an estimated $93.2K.
  • West Pharmaceutical made up 0.05% of Landsberg Bennett & Dubbaneh's portfolio in Q3 2021, its #188 holding.
  • Landsberg Bennett & Dubbaneh first reported a position in West Pharmaceutical in Q2 2021 and has held it in 2 quarters since.
  • 670 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2021.

Based on Landsberg Bennett & Dubbaneh's 13F filing for Q3 2021, filed 29 Oct 2021.